A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...

PHILADELPHIA — Interleukin-17 inhibition with bimekizumab yields strong joint and skin effects up to week 52 in patients with active psoriatic arthritis, according to data presented at ACR Convergence ...

Adverse effects associated with glucocorticoid use among patients with rheumatoid arthritis may not be as burdensome as previously indicated. Glucocorticoids are one of the most common methods for ...

A recent meta-analysis examined 217 trials involving 15,684 participants and six types of exercise to manage knee ...

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

Rheumatoid arthritis (RA) affects joints but also eyes, lungs, and other body systems. RA can increase the risk of osteoporosis, leading to bone loss and weakness. RA medications can cause skin ...

Please provide your email address to receive an email when new articles are posted on . Persistently elevated ESR and CRP in patients with RA were associated with greater risk for interstitial lung ...

LONDON (Reuters) - A new arthritis drug made by Merck & Co. causes fewer stomach disorders and complications than an older painkiller, researchers said on Friday. They analyzed the results of three ...

It’s important to taper steroid medications gradually to avoid unpleasant side effects, but tapering schedules will depend on individual needs and may differ for everyone. A doctor can work with you ...